お問い合わせcontact
ご相談・ご質問などお気軽にお寄せください
- 公立大学法人福島県立医科大学 消化管外科学講座
〒960-1295 福島県福島市光が丘1
TEL 024-547-1111（代表）
MAIL gi-tsurg@fmu.ac.jp
（分類は大学の業績集に準じています）
| 1. | Abubakar AK, Kaneda Y, Ozaki A, Saito H, Murakami M, Hori D, Gonda K, Tsubokura M, Tabuchi T. Two-Year-Span Breast Cancer Screening Uptake in Japan after the COVID-19 Pandemic and Its Association with the COVID-19 Vaccination. Cancers（Basel）.16（9）:1783, 2024. |
|---|---|
| 2. | Booka E, Takeuchi H, Kikuchi H, Miura A, Kanda M, Kawaguchi Y, Hamai Y, Nasu M, Sato S, Inoue M, Okubo K, Ogawa R, Sato H, Yoshino S, Takebayashi K, Kono K, Toh Y, Katori Y. A nationwide survey on the safety of cricothyrotomy: a multicenter retrospective study in Japan. Esophagus. 22（1）: 19-26, 2025. |
| 3. | Dalal B, Tada T, Patel DP, Pine SR, Khan M, Oike T, Kanke Y, Parker AL, Haznadar M, Toulabi L, Krausz KW, Robles AI, Bowman ED, Gonzalez FJ, Harris CC. Urinary Metabolite Diagnostic and Prognostic Liquid Biopsy Biomarkers of Lung Cancer in Nonsmokers and Tobacco Smokers. Clin Cancer Res. 30（16）: 3592-3602, 2024. |
| 4. | Fujiwara Y, Takahashi RU, Saito M, Umakoshi M, Shimada Y, Koyama K, Yatabe Y, Watanabe SI, Koyota S, Minamiya Y, Tahara H, Kono K, Shiraishi K, Kohno T, Goto A, Tsuchiya N. Oncofetal IGF2BP3-mediated control of microRNA structural diversity in the malignancy of early-stage lung adenocarcinoma. Proc Natl Acad Sci U S A. 121（36）: e2407016121, 2024. |
| 5. | Hasegawa M, Sanmoto Y, Kono K. Impact of the Combination of Anamorelin and Rehabilitation on Functional and Nutritional Outcomes in Patients with Cancer Cachexia. Nutr Cancer. 29: 1-7, 2024. |
| 6. | Hasegawa M, Sanmoto Y. Effect of Preoperative Geriatric Nutritional Risk Index on Prognosis in Patients after Surgery for Lower Gastrointestinal Perforation. Ann Nutr Metab. 8（0 2024. |
| 7. | Hashimoto Y, Abe N, Nunobe S, Kawakubo H, Sumiyoshi T, Yoshida N, Morita Y, Terashima M, Saze Z, Onimaru M, Otsuji E, Hoteya S, Yamashita H, Fujimura T, Oyama T, Ohata K, Shichijo S, Tanabe K, Shuto K, Ikeya T, Shinohara H, Tanabe S, Hiki N. Outcomes of laparoscopic and endoscopic cooperative surgery for gastric submucosal tumors: A retrospective multicenter study at 21 Japanese institutions. Ann Gastroenterol Surg. 8（5）: 778- 786, 2024. |
| 8. | Hoshi N, Uemura T, Tachibana K, Abe S, Murakami-Nishimagi Y, Okano M, Noda M, Saito K, Kono K, Ohtake T, Waguri S. Endosomal protein expression of γ1-adaptin is associated with tumor growth activity and relapse-free survival in breast cancer. Breast Cancer. 31（2）: 305-316, 2024. |
| 9. | Kameoka E, Hikichi T, Hashimoto M, Nakamura J, Kato T, Yanagita T, Sakamoto W, Kobayakawa M, Hashimoto Y, Ohira H. Rectal implantation cyst successfully diagnosed using endoscopic myotomy and endoscopic ultrasonography. Clin J Gastroenterol. 17（4）: 647-653, 2024. |
| 10. | Kaneda Y, Yamashita E, Saito H, Gonda K, Wada M, Tanimoto T, Ozaki A. Increasing trends of pharmaceutical payments to breast cancer specialists in Japan: A retrospective study from 2016 to 2019. PLoS One. 19（9）: e0310880, 2024. |
| 11. | Kanoda R, Nakajima S, Fukai S, Saito M, Saito K, Suzuki H, Kikuchi T, Nirei A, Okayama H, Mimura K, Hanayama H, Sakamoto W, Momma T, Saze Z, Kono K. High levels of tumor cell- intrinsic STING signaling are associated with increased infiltration of CD8+ T cells in dMMR/ MSI-H gastric cancer. Sci Rep. 14（1）: 20859, 2024. |
| 12. | Maruyama Y, Saito M, Nakajima S, Saito K, Suzuki H, Kanoda R, Okayama H, Hanayama H, Sakamoto W, Saze Z, Momma T, Mimura K, Goto A, Kono K. Lenvatinib suppress FGF19-FGFR4 signaling to enhance antitumor immune response in gastric cancer. Gastric Cancer. Online ahead of print, 2025. |
| 13. | Matsuishi A, Nakajima S, Kaneta A, Saito K, Fukai S, Sakuma M, Tsumuraya H, Okayama H, Saito M, Mimura K, Nirei A, Kikuchi T, Hanayama H, Saze Z, Sakamoto W, Momma T, Kono K. The tumor cell-intrinsic cGAS-STING pathway is associated with the high density of CD8+ T cells after chemotherapy in esophageal squamous cell carcinoma. Esophagus. 21（2）: 165-175, 2024. |
| 14. | Matsuishi A, Nakajima S, Saito M, Saito K, Fukai S, Tsumuraya H, Kanoda R, Kikuchi T, Nirei A, Kaneta A, Okayama H, Mimura K, Hanayama H, Sakamoto W, Momma T, Saze Z, Kono K. The impact of CLDN18.2 expression on effector cells mediating antibody-dependent cellular cytotoxicity in gastric cancer. Sci Rep. 14（1）: 17916, 2024. |
| 15. | Mimura K, Ogata T, Nguyen PHD, Roy S, Kared H, Yuan YC, Fehlings M, Yoshimoto Y, Yoshida D, Nakajima S, Sato H, Machida N, Yamada T, Watanabe Y, Tamaki T, Fujikawa H, Inokuchi Y, Hayase S, Hanayama H, Saze Z, Katoh H, Takahashi F, Oshima T, Goel A, Nardin A, Suzuki Y, Kono K. Combination of oligo-fractionated irradiation with nivolumab can induce immune modulation in gastric cancer. J Immunother Cancer. 12（1）: e008385, 2024. |
| 16. | Miyakawa T, Honda M, Kawamura H, Yamamoto R, Toshiyama S, Mashiko R, Kakinuma H, Hori S, Nakao E, Todate Y, Takano Y, Kono K. Appropriate timing for the removal of urinary catheters in gastrointestinal surgery with epidural anesthesia: a randomized controlled trial. Langenbecks Arch Surg. 409（1）: 265, 2024. |
| 17. | 17. Miwa M, Kitagawa M, Asami Y, Kobayashi-Kato M, Watanabe T, Ogasawara A, Hiranuma K, Kato H, Saito M, Miyagi Y, Kato T, Yoshida H, Momozawa Y, Kohno T, Shiraishi K, Hasegawa K. Prevalence and outcomes of germline pathogenic variants of homologous recombination repair genes in ovarian cancer. Cancer Sci. 115（12）: 3952-3962, 2024. |
| 18. | Nakajima S, Saito K, Fukai S, Sakuma M, Matsuishi A, Kanoda R, Maruyama Y, Suzuki H, Okayama H, Saito M, Mimura K, Nirei A, Kikuchi T, Hanayama H, Saze Z, Momma T, Nishiyama K, Suzutani T, Kono K. Activation of the tumor cell-intrinsic STING pathway induced by Fusobacterium nucleatum is associated with poor prognosis in esophageal cancer patients. Esophagus. Online ahead of print, 2025 |
| 19. | Nakao E, Kawamura H, Honda M, Takano Y, Kinuta S, Kamiga T, Yamazaki S, Muto A, Shiraso S, Yamashita N, Iwao T, Kono K, Konno S. Prognostic impact and survival outcomes of colon perforation in patients with metastatic colorectal cancer: a multicenter retrospective cohort study. Int J Clin Oncol. 29（2）: 179-187, 2024. |
| 20. | Nakao E, Honda M, Uesugi N, Osakabe M, Sato A, Todate Y, Yaegashi M, Takano Y, Sasaki A, Kono K, Sugai T. Evaluation of the prognostic impact of pathologic tumor regression grade on patients with colorectal cancer after preoperative chemoradiotherapy. J Surg Oncol. 129（8）: 1521-1533, 2024. |
| 21. | Ogawa K, Ishikawa H, Toyozumi T, Noma K, Kono K, Hojo H, Tamamura H, Azami Y, Ishida T, Nabeya Y, Iwata H, Araya M, Tokumaru S, Maruo K, Oda T, Matsubara H. Comparison of proton-based definitive chemoradiotherapy and surgery-based therapy for esophageal squamous cell carcinoma: a multi-center retrospective Japanese cohort study. Esophagus. 21（4）: 484-494, 2024. |
| 22. | Okamura A, Watanabe M, Okui J, Matsuda S, Takemura R, Kawakubo H, Kakeji Y, Kono K, Kitagawa Y, Takeuchi H. Outcomes of patients with esophageal squamous cell carcinoma who achieved a pathological complete response in the primary lesion by neoadjuvant treatment: a Japanese nationwide cohort study. Esophagus. 21（1）: 2-10, 2024. |
| 23. | Okamura A, Watanabe M, Okui J, Kuriyama K, Shiraishi O, Kurogochi T, Abe T, Sato H, Miyata H, Kawaguchi Y, Sato Y, Nagano H, Takeno S, Nakajima M, Matsuo K, Murakami K, Takebayashi K, Matsumoto S, Okumura T, Kakeji Y, Kono K, Oridate N, Toh Y, Takeuchi H, Katori Y; Joint Research between the Japan Broncho-esophagological Society and the Japan Esophageal Society. Esophagectomy for esophageal cancer in patients with a history of total pharyngolaryngectomy: a Japanese nationwide retrospective cohort study. Esophagus. 21（4）: 438-446, 2024. |
| 24. | Okui J, Nagashima K, Matsuda S, Sato Y, Okamura A, Kawakubo H, Muto M, Kakeji Y, Kono K, Takeuchi H, Watanabe M, Doki Y, Bamba T, Fukuda T, Fujiwara H, Sato S, Noma K, Miyata H, Fujita T, Kitagawa Y. Recurrence-free survival as a surrogate endpoint for overall survival after neoadjuvant chemotherapy and surgery for oesophageal squamous cell carcinoma. Br J Surg. 111（2）: znae038, 2024. |
| 25. | Sakuma M, Katagata M, Okayama H, Nakajima S, Saito K, Sato T, Fukai S, Tsumuraya H, Onozawa H, Sakamoto W, Saito M, Saze Z, Momma T, Mimura K, Kono K. TIM-3 Expression on Dendritic Cells in Colorectal Cancer. Cancers（Basel）. 16（10）: 1888, 2024. |
| 26. | Sanmoto Y, Hasegawa M, Kinuta S. Factors contributing to prolonged operative time for laparoscopic cholecystectomy performed by trainee surgeons: a retrospective single-center study. Surg Today. 54（11）: 1395-1400, 2024. |
| 27. | Sato S, Suzuki T, Chinen T, Yamaguchi H, Suzuki Y, Hokamura N, Saze Z, Kono K, Takahashi K, Yano F, Kunisaki C, Kosaka T, Endo I, Ichikawa Y, Miyawaki Y, Sato H, Shimada H. The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study. Int J Clin Oncol. 29（7）: 994- 1001, 2024. |
| 28. | Sato S, Suzuki T, Chinen T, Yamaguchi H, Suzuki Y, Hokamura N, Saze Z, Kono K, Takahashi K, Yano F, Sato T, Kosaka T, Endo I, Ichikawa Y, Miyawaki Y, Sato H, Shimada H. Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases. J Gastroenterol. 59（11）: 979-985, 2024. |
| 29. | Shiraishi K, Takahashi A, Momozawa Y, Daigo Y, Kaneko S, Kawaguchi T, Kunitoh H, Matsumoto S, Horinouchi H, Goto A, Honda T, Shimizu K, Torasawa M, Takayanagi D, Saito M, Saito A, Ohe Y, Watanabe SI, Goto K, Tsuboi M, Tsuchihara K, Takata S, Aoi T, Takano A, Kobayashi M, Miyagi Y, Tanaka K, Suzuki H, Maeda D, Yamaura T, Matsuda M, Shimada Y, Mizuno T, Sakamoto H, Yoshida T, Goto Y, Yoshida T, Yamaji T, Sonobe M, Toyooka S, Yoneda K, Masago K, Tanaka F, Hara M, Fuse N, Nishizuka SS, Motoi N, Sawada N, Nishida Y, Kumada K, Takeuchi K, Tanno K, Yatabe Y, Sunami K, Hishida T, Miyazaki Y, Ito H,
Amemiya M, Totsuka H, Nakayama H, Yokose T, Ishigaki K, Nagashima T, Ohtaki Y, Imai K, Takasawa K, Minamiya Y, Kobayashi K, Okubo K, Wakai K, Shimizu A, Yamamoto M, Iwasaki M, Matsuda K, Inazawa J, Shiraishi Y, Nishikawa H, Murakami Y, Kubo M, Matsuda F, Kamatani Y, Hamamoto R, Matsuo K, Kohno T. Identification of telomere maintenance gene variations related to lung adenocarcinoma risk by genome-wide association and whole genome sequencing analyses. Cancer Commun（Lond）. 44（2）: 287-293, 2024. |
| 30. | Singh P, Montesino S, Ozaki A, Murakami M, Kaneda Y, Abe T, Zhao T, Yamamoto C, Ito N, Amir I, Yamashita E, Saito H, Sawano T, Gonda K, Ohira H, Yanagisawa R, Katz C, Tsubokura M. Medical Access and Care Continuity: Qualitative Assessments of Patients with Breast Cancer and Family Members’ Experiences Following the 2011 Triple Disaster in Fukushima, Japan. Disaster Med Public Health Prep. 18: e257, 2024. |
| 31. | Takagawa Y, Suzuki M, Seto I, Azami Y, Machida M, Takayama K, Sulaiman NS, Nakasato T, Kikuchi Y, Murakami M, Honda M, Teranishi Y, Kono K. Proton beam reirradiation for locally recurrent rectal cancer patients with prior pelvic irradiation. J Radiat Res. 65（3）: 379-386, 2024.. |
| 32. | Takagawa Y, Machida M, Seto I, Komori S, Sato H, Endo H, Midorikawa H, Kato T, Murakami M, Honda M, Kono K. Analysis of operative duration of image-guided brachytherapy for cervical cancer. Strahlenther Onkol. Online ahead of print, 2024. |
| 33. | Takao M, Yamaguchi T, Eguchi H, Suzuki O, Mori Y, Chika N, Yamada T, Okazaki Y, Tomita N, Nomizu T, Momma T, Takayama T, Tanakaya K, Akagi K, Tanabe N, Ishida H. Predictive modeling for the germline pathogenic variant of the APC gene in patients with adenomatous polyposis: proposing a new APC score. Surg Today. Online ahead of print, 2024. |
| 34. | Todate Y, Takada T, Honda M, Miyakawa T, Yamamoto R, Toshiyama S, Nakao E, Mashiko R, Kakinuma H, Kawamura H, Yamaguchi H, Takagawa Y, Kono K. Radiological Cutoff Values for Diagnosis of Lymph Node Metastasis in Colorectal Cancer With Multilevel Analysis. Cancer Diagn Progn. 4（3）: 333-339, 2024. |
| 35. | Tsuji T, Matsuda S, Sato Y, Tanaka K, Sasaki K, Watanabe M, Hamai Y, Nasu M, Saze Z, Nakashima Y, Nomura M, Yamamoto S, Booka E, Ishiyama K, Bamba T, Sakanaka K, Tsushima T, Takeuchi H, Kato K, Kawakubo H. Safety and Efficacy of Conversion Therapy After Systemic Chemotherapy in Advanced Esophageal Cancer with Distant Metastases: A Multicenter Retrospective Observational Study. Ann Surg Oncol. 32（1）: 274-283, 2025. |
| 36. | Tsuji T, Matsuda S, Sato Y, Tanaka K, Sasaki K, Watanabe M, Hamai Y, Nasu M, Saze Z, Nakashima Y, Nomura M, Yamamoto S, Booka E, Ishiyama K, Bamba T, Sakanaka K, Tsushima T, Takeuchi H, Kato K, Kawakubo H. ASO Author Reflections: Can Conversion Therapy be an Option for Advanced Esophageal Cancer with Distant Metastases? Ann Surg Oncol. 32（1）: 325-326, 2025.. |
| 37. | Tsumuraya H, Okayama H, Katagata M, Matsuishi A, Fukai S, Ito M, Sakamoto W, Saito M, Momma T, Nakajima S, Mimura K, Kono K. TGF β -Responsive Stromal Activation Occurs Early in Serrated Colorectal Carcinogenesis. Int J Mol Sci. 25（9）:4626, 2024. |
| 38. | Tsumuraya H, Mimura K, Nakajima S, Hanayama H, Matsuishi A, Okayama H, Fukai S, Ito M, Ashizawa M, Chida S, Onozawa H, Sakamoto W, Saito M, Saze Z, Momma T, Kono K. Tumor Infiltrating Effector Regulatory T Cells Express VEGF Receptor 2 in Patients With Colorectal Cancer. Anticancer Res. 44（7）: 2933-2941, 2024. |
| 39. | Watanabe J, Kimura T, Saze Z, Sato N, Kofunato Y, Ishigame T, Okada R, Kenjo A, Kono K, Marubashi S. The ratio of intratumoral CD15+ neutrophils to CD8+ lymphocytes predicts recurrence in patients with gastric cancer after curative resection. Cancer Rep（Hoboken）. 7（6）: e2099, 2024. |
| 40. | Yamashita S, Miura K, Matsuura A, Yamasaki N, Uda N, Ogata S, Hosomi N, Nakajima S, Kitamura N, Gotoh M, Mori A, Kaminuma O. α7 nicotinic acetylcholine receptor agonist attenuates allergen-induced immediate nasal response in murine model of allergic rhinitis. J Vet Med Sci. 86（7）: 824-827, 2024. |
| 1. | Kakeji Y, Yamamoto H, Watanabe M, Kono K, Ueno H, Doki Y, Kitagawa Y, Takeuchi H, Shirabe K, Seto Y. Outcome research on esophagectomy analyzed using nationwide databases in Japan: evidences generated from real-world data. Esophagus. 21（4）: 411-418, 2024. |
|---|---|
| 2. | Kaneda Y, Ozaki A, Tachibana K, Wada M, Gonda K, Tanimoto T, Shimmura H, Jakovljevic M. How should medical society face patient feedback in online review platforms? Int J Qual Health Care. 36（3）: mzae075, 2024. |
| 3. | Kono K, Nakajima S, Mimura K. Biomarker-oriented chemo-immunotherapy for advanced gastric cancer. Int J Clin Oncol. 29（7）: 865-872, 2024. |
| 4. | Ozaki A, Azami A, Azami Y, Sugeno T, Yasui A, Gonda K, Tanimoto T, Tachibana K, Ohtake T. Fukushima Outpatient Pharmacotherapy Model for Breast Cancer. JMA J. 7（4）: 618-621, 2024. |
| 5. | Yasui A, Kinoshita S, Endo M, Kaneda Y, Ikeguchi R, Yamamoto C, Abe T, Zhao T, Sawano T, Gonda K, Tsubokura M, Beniya H, Shimmura H, Ozaki A. Disaster response and older adult cancer care in super-aged societies: insights from the 2024 Noto Peninsula Earthquake in Oku- Noto, Japan. Front Public Health. 12: 1427987, 2024. |
| 6. | 河野浩二．基調講演 食道癌における治療介在による腫瘍微小環境リモデリング．日本気管食道科学会会報．75（2）: 139，2024. |
| 7. | 齋藤元伸．福島医大のゲノム医療とがん免疫療法（会議録）．福島医学雑誌．74（2）: 47，2024. |
| 8. | 柴田昌彦，成田尚也，大野史絵，伊藤絵美，矢澤貴，長谷川翔，井上典夫，持田謙介，前田佳一 郎，南嘉輝，遠藤俊吾，高田信，鈴木義行，河野浩二，竹之下誠一．山間部の中核病院，がん治療センター開設 365 日（解説）．癌と化学療法．51（2）:153-158, 2024． |
| 9. | 中嶋正太郎，深井智司，金田晃尚，圓谷秀哲，松石彬，岡山洋和，齋藤元伸，三村耕作，坂本渉，佐瀬善一郎，門馬智之，河野浩二．胃癌における HER2 シグナルを介した腫瘍微小環境の制御― HER2 過剰発現の腫瘍内不均一性を呈する胃癌症例からの検討―．癌と化学療法．51（9）: 903-905, 2024. |
| 1. | Hasegawa M, Kikuchi T, Yago H, Mitsui D, Matsuishi A, Tsumuraya H, Kaneta A, Matsuida H, Nirei A, Hanayama H, Saze Z, Takase S, Kono K. Cardiac tamponade caused by a ruptured coronary aneurysm treated with open-chest hemostasis after esophageal cancer surgery: a case report. J Surg Case Rep. 2024（8）: rjae555, 2024. |
|---|---|
| 2. | Hasegawa M, Sanmoto Y. Recurrent cholangitis and bacteraemia due to Edwardsiella tarda: a case report. Oxf Med Case Reports. 2024（1）: omad148, 2024. |
| 3. | Hasegawa M, Sanmoto Y, Kinuta S. Laparoscopic repair of Morgagni hernia by primary closure with extra-abdominal suture: a case report and review of the literature. Pan Afr Med J. 47: 150, 2024. |
| 4. | Kaneda Y, Gonda K, Asakura T, Wada M, Sawano T, Kurokawa T, Tachibana K, Ozaki A. Pneumocystis Pneumonia in Locally Advanced Breast Cancer Despite Prophylactic Use of Trimethoprim-Sulfamethoxazole During Prednisolone Treatment for a Pembrolizumab-Induced Immune-Related Adverse Event: A Case Report. Cureus. 16（3）: e56868, 2024. |
| 5. | Kanoda R, Kikuchi T, Utsumi A, Mochizuki S, Matsuishi A, Kaneta A, Nirei A, Hanayama H, Saze Z, Hikichi T, Hashimoto Y, Kono K. Thoracoscopic and endoscopic cooperative surgery for esophageal gastrointestinal stromal tumor: a case report. Surg Case Rep. 10（1）: 237, 2024. |
| 6. | Ueda M, Watanabe T, Momma T, Kanke Y, Kato A, Okabe C, Sato T, Kamo N, Endo Y, Furukawa S, Soeda S, Fujimori K. Diaphragmatic clear cell carcinoma with Lynch syndrome after surgery for atypical endometrial hyperplasia and ovarian endometriosis: A case report. Mol Clin Oncol. 21（1）: 46, 2024. |
| 7. | Kawamata T, Shibata M, Imoto T, Takiguchi C, Aoto K, Hayase S, Saito M, Ami H, Koyama Y, Kono K. A case of oxaliplatin-induced thrombocytopenia followed by complete remission of metastatic colon cancer. Int J Clin Case Rep Rev. 19（1）: 538, 2024. |
| 8. | 叶多諒，花山寛之，松石彬，丸山裕也，目黒啓予，松井田元，金田晃尚，楡井東，菊池智宏，佐瀬善一郎，橋本優子， 河野浩二．腹腔鏡下に切除した腫瘍内感染を伴う胃 gastrointestinal stromal tumor の 1 例．福島医学雑誌．74（2）: 41-46, 2024. |
| 9. | 叶多諒，仲野宏，鈴木博也，林下宗平，佐久間芽衣，金澤匡司．骨盤死腔炎治療中に発症したメ トロニダゾール脳症の 1 例．日本農村医学会雑誌．73（4）: 390-396, 2024. |
| 10. | 千田峻，木口託見，深井智司，伊藤美郷，芦澤舞，小野澤寿志，岡山洋和，坂本渉，齋藤元伸，門馬智之，河野浩二．憩室内に発生した早期 S 状結腸癌を腹腔鏡補助下に局所切除した 1 例．癌と化学療法．51（13）: 1312-1314, 2024. |
| 11. | 林下宗平，遠藤英成，佐久間芽衣，大木進司，金澤匡司．Peutz-Jeghers 型ポリープにより腸重積に対して緊急手術を行なったベトナム人男性の 1 例．日本農村医学会雑誌．73（3）: 250, 2024． |
| 12. | 12. 星野啓太，藤田正太郎，中島隆宏，八島玲，河野浩二．集学的治療により長期生存が得られた穿孔性 S 状結腸癌 , 同時性肝転移の 1 例．癌と化学療法．51（13）: 1393-1395, 2024. |
| 13. | 宮本康太郎，山口大輝，多田武志，中山浩一，浦住幸治郎．小腸間膜に発生した巨大デスモイド腫瘍の 1 例．癌と化学療法．51（10）: 1059-1061, 2024. |
| 1. | 掛地吉弘，渡邊雅之，河野浩二，上野秀樹，土岐祐一郎，北川雄光，竹内裕也，調憲，瀬戸泰之． 特集 合併症を起こさない食道癌手術！―ハイボリュームセンターの技を学ぼう 食道癌術後合併症の現状 National Clinical Database からみる食道癌術後合併症と手術死亡率．臨床外科 別冊 79（8）: 840-844, 2024. |
|---|---|
| 2. | 齋藤元伸．いますぐ役立つがんゲノム医療の手引：消化器外科医のために．2024. |
| 3. | 佐瀬善一郎，河野浩二．Gambee 縫合を用いたロボット支援上川法再建―トルネード法による運針手技．手術 78（5）: 839-846, 2024. |
| 4. | 中嶋正太郎，河野浩二．III．食道癌の生物学 食道癌の腫瘍免疫微小環境 . 日本臨床 食道癌2024 －基礎・臨床の最新動向－ . 82（3）: 90-95, 2024. |
| 5. | 柴田昌彦，中野隆史． The future of cancer treatment がん治療の未来．SHIORI. 43 : 14-21, 2024 |
| 6. | 柴田昌彦，遠藤俊吾．これからの会津の医療を考える．SHIORI. 44 : 82-95, 2024 |
ご相談・ご質問などお気軽にお寄せください